mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.096 |
0.05 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.06 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.56 |
0.06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |